4.6 Article

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

Related references

Note: Only part of the references are listed.
Review Oncology

Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis

Chen Nahshon et al.

Summary: Short-term survival rates of BRCA-mutated ovarian cancer patients are higher, but the advantage diminishes over time. The relatively low long-term survival rate highlights the significance of preventing epithelial ovarian cancer recurrence.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Article Oncology

Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

Julia C. F. Quintanilha et al.

Summary: A genome-wide association study (GWAS) meta-analysis was conducted in European ancestry bevacizumab-treated patients, identifying significant SNPs associated with hypertension and proteinuria, providing new markers for predicting toxicities induced by bevacizumab.

BRITISH JOURNAL OF CANCER (2022)

Article Pharmacology & Pharmacy

Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical-Biomolecular Markers Significantly Associated with Toxicity

Luca Bedon et al.

Summary: Machine learning algorithms have been used to predict clinical outcomes and drug toxicity. In phase I clinical trials, training ML algorithms with clinical, blood biochemistry, and genotype data can help predict toxicity and find new indicators related to drug metabolism equilibrium.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Review Oncology

VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications

Nicholas Camarda et al.

Summary: This review summarizes recent advances in understanding the molecular mechanisms and clinical findings of VEGFRi-induced hypertension, exploring the connections between endothelial dysfunction, vascular mechanical properties, and genetic polymorphisms. These studies have important implications for the future development of cardio-oncology clinics and the management of hypertension.

CURRENT ONCOLOGY REPORTS (2022)

Article Oncology

Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020

Citadel J. Cabasag et al.

Summary: This study provides an overview of the global burden of ovarian cancer and predicts the future burden, particularly in low Human Development Index (HDI) countries. It shows geographic variations in incidence and mortality rates, with higher burden in low HDI countries. The study highlights the need for global action to reduce the burden and inequality of ovarian cancer in access to quality cancer care and treatment.

INTERNATIONAL JOURNAL OF CANCER (2022)

Review Computer Science, Artificial Intelligence

Don't lose samples to estimation

Ioannis Tsamardinos

Summary: In a predictive modeling task, it is unacceptable to lose samples for estimation when data size is low. Instead, we need to estimate the performance of the pipeline that produces the model by training it on subsets of the samples. This avoids losing data to estimation and provides a more accurate estimate of the model's performance.

PATTERNS (2022)

Article Medicine, Research & Experimental

Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk

Elena De Mattia et al.

Summary: This study demonstrated that the burden of rare DPYD variants is significantly associated with higher risk of severe fluoropyrimidine-related toxicity. Through the use of next generation sequencing and in silico predictive tools, the functional impact of these rare variants was evaluated, providing insights into their potential role in predicting adverse reactions to chemotherapy drugs.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Oncology

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study

Gennaro Daniele et al.

Summary: The study investigated the clinical and biological prognostic factors for advanced ovarian cancer patients receiving first-line treatment with carboplatin, paclitaxel, and bevacizumab. Results showed that the progression-free survival and overall survival were 20.8 months and 41.1 months, respectively. Clinical factors such as performance status, stage, and residual disease after primary surgery were significant predictors of survival outcomes.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Pharmacology & Pharmacy

An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

Michelle Whirl-Carrillo et al.

Summary: Clinical annotations in PharmGKB summarize the association between variant-drug pairs and are assigned a level of evidence. To ensure consistency and transparency, a scoring system has been developed to automate LOE assignment. This system improves the quality and reliability of clinical annotations.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Multidisciplinary Sciences

Machine learning algorithm validation with a limited sample size

Andrius Vabalas et al.

PLOS ONE (2019)

Review Pharmacology & Pharmacy

Bevacizumab-induced hypertension: Clinical presentation and molecular understanding

Megan Li et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Cell Biology

Genetic variants in mRNA untranslated regions

Maristella Steri et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)

Article Biochemical Research Methods

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Zuguang Gu et al.

BIOINFORMATICS (2016)

Article Biotechnology & Applied Microbiology

Single Nucleotide Polymorphisms in MicroRNA Binding Sites of Oncogenes: Implications in Cancer and Pharmacogenomics

Mayakannan Manikandan et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2014)

Article Genetics & Heredity

A microRNA-520 mirSNP at the MMP2 gene influences susceptibility to endometriosis in Chinese women

Eing-Mei Tsai et al.

JOURNAL OF HUMAN GENETICS (2013)

Review Biochemistry & Molecular Biology

Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents

Kafait U. Malik et al.

PROSTAGLANDINS & OTHER LIPID MEDIATORS (2012)

Article Medicine, General & Internal

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy J. Perren et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Peripheral Vascular Disease

Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A. Meta-Analysis

Vishal Ranpura et al.

AMERICAN JOURNAL OF HYPERTENSION (2010)

Article Computer Science, Interdisciplinary Applications

Feature Selection with the Boruta Package

Miron B. Kursa et al.

JOURNAL OF STATISTICAL SOFTWARE (2010)

Review Cardiac & Cardiovascular Systems

The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease

Simon W. Rabkin

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2009)

Article Pharmacology & Pharmacy

Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects

Kyoung-Ah Kim et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Article Computer Science, Artificial Intelligence

Random forests

L Breiman

MACHINE LEARNING (2001)

Article Statistics & Probability

Greedy function approximation: A gradient boosting machine

JH Friedman

ANNALS OF STATISTICS (2001)